Junichi Muraishi Michihiko Shibata Yuichi Honma Masaaki Hiura Shintaro Abe Masaru Harada
10.2169/internalmedicine.56.8233
Intern Med
2017;56(15):1967-1971.
hbv entecavir reactivation rituximab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28768965/
Antiviral Agents / therapeutic use Guanine / analogs & derivatives Hepatitis B / drug therapy Hepatitis B virus / physiology Lymphoma / drug therapy Rituximab / therapeutic use
Antiviral Agents / therapeutic use Guanine / analogs & derivatives Hepatitis B / drug therapy Hepatitis B virus / physiology Lymphoma / drug therapy Rituximab / therapeutic use Case Reports Aged Antibodies, Monoclonal, Murine-Derived / therapeutic use Antiviral Agents / administration & dosage Guanine / administration & dosage Guanine / therapeutic use Hepatitis B / physiopathology Hepatitis B Antibodies Hepatitis B Surface Antigens / blood Hepatitis B e Antigens Humans Male Rituximab / administration & dosage Virus Activation Antibodies, Monoclonal, Murine-Derived Antiviral Agents Hepatitis B Antibodies Hepatitis B Surface Antigens Hepatitis B e Antigens Rituximab entecavir Guanine
PMC5577071
28768965
Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma
2017